UNICYCIVE THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20__ SUBORDINATED DEBT SECURITIESUnicycive Therapeutics, Inc. • November 13th, 2024 • Pharmaceutical preparations • New York
INDENTURE , dated as of [ ● ], among Unicycive Therapeutics, Inc. , a Delaware corporation (the “Company”), and [ TRUSTEE ], as trustee (the “Trustee”):
UNICYCIVE THERAPEUTICS, INC. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • November 13th, 2024 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • New York
Unicycive Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Guggenheim Securities, LLC (the “Agent”), as follows:
UNICYCIVE THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20__ SENIOR DEBT SECURITIESIndenture • November 13th, 2024 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], among Unicycive Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
